CAN
GILD icon

Claraphi Advisory Network’s Gilead Sciences GILD Stock Holding History

Claraphi Advisory Network’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,298
Closed -$254K – 275
2020
Q2 		$254K Sell
3,298
-485
-13% -$37.2K 0.11% 189
2020
Q1 		$283K Buy
+3,783
New +$261K 0.13% 145
2019
Q3 		– Sell
-3,222
Closed -$218K – 414
2019
Q2 		$218K Buy
+3,222
New +$212K 0.13% 199

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Claraphi Advisory Network's GILD Position: Q3 2020 in Review

Claraphi Advisory Network sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 3,298 shares — an estimated $254K sold.

Claraphi Advisory Network first reported a position in GILD in Q2 2019 and held it in 3 quarters. The position peaked at $283K in Q1 2020. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

  • Claraphi Advisory Network reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
  • Claraphi Advisory Network sold 3,298 Gilead Sciences shares in Q3 2020, an estimated $254K.
  • Claraphi Advisory Network first reported a position in Gilead Sciences in Q2 2019 and held it in 3 quarters.
  • Claraphi Advisory Network's Gilead Sciences position peaked at $283K in Q1 2020.
  • 1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Claraphi Advisory Network's 13F filing for Q3 2020, filed 13 Nov 2020.